Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 17

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 17
---
 we do offer securities through agents or underwriters, we will include in the applicable
prospectus supplement:

| · | the name of those agents or underwriters; |

| · | applicable fees, discounts and commissions to 
 be paid to them;                              |

| · | details regarding options to purchase additional 
 securities, if any; and                          |

| · | the net proceeds to us. |

Common Stock.

We may issue shares of our
common stock from time to time. Holders of our common stock are entitled to one vote per share on all matters submitted to a vote of shareholders.
Subject to any preferences of any of our preferred stock that may be outstanding, holders of our common stock are entitled to dividends
when and if declared by our board of directors.

Preferred Stock.

Our board of directors has
the authority, subject to limitations prescribed by Washington law, to issue preferred stock in one or more series, to establish from
time to time the number of shares to be included in each series, and to fix or alter the rights, preferences and privileges of the preferred
stock, along with any limitations or restrictions, including voting rights, dividend rights, conversion rights, redemption privileges
and liquidation preferences of each class or series of preferred stock.

Each series of preferred stock,
if issued, will be more fully described in the particular prospectus supplement that will accompany this prospectus, including redemption
provisions, rights in the event of our liquidation, dissolution or winding-up, voting rights and rights to convert into common stock.

Warrants.

We may issue warrants for
the purchase of common stock or preferred stock, in one or more series, from time to time. We may issue warrants independently or together
with common stock, preferred stock or debt securities, and the warrants may be attached to or separate from our common stock, preferred
stock or debt securities. In this prospectus, we have summarized certain general features of the warrants. We urge you, however, to read
the applicable prospectus supplement (and any free writing prospectus that we may authorize to be provided to you) related to the particular
series of warrants being offered, as well as the complete warrant agreement and warrant certificate that contain the terms of the warrants.
We will file as an exhibit to the registration statement of which this prospectus is a part, or will incorporate by reference from reports
that we file with the SEC, the form of warrant agreement, including a form of warrant certificate, that describes the terms of the particular
series of warrants